Skip to main content
Clinical Trials/NCT03912584
NCT03912584
Completed
Not Applicable

Qualitative OCT Image Grading Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Optos, PLC1 site in 1 country10 target enrollmentApril 29, 2019
ConditionsGlaucoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Optos, PLC
Enrollment
10
Locations
1
Primary Endpoint
Qualitative B-Scan Assessment
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The study evaluates the image quality between two OCT devices.

Detailed Description

The objective of this study is to collect OCT scans to compare the qualitative B scan images produced by the P200TxE to the P200TE device in glaucoma subjects.

Registry
clinicaltrials.gov
Start Date
April 29, 2019
End Date
April 30, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Optos, PLC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
  • Subjects who can follow the instructions by the clinical staff at the clinical site,
  • Subjects who agree to participate in the study;
  • Subjects who have been diagnosed with glaucoma in the study eye as confirmed by the investigator;

Exclusion Criteria

  • Subjects unable to tolerate ophthalmic imaging;
  • Subjects with ocular media not sufficiently clear to obtain acceptable OCT images;
  • Subjects with any clinically significant ocular pathology except glaucoma, as determined by self-report and/or investigator assessment on the day of the study visit;
  • Subjects who are not reliably tested with at least one Humphrey Field Analyzer (HFA) visual field (24-2 or 30-2, white on white) measured on the day of the study visit or within the previous year from the study visit, defined as fixation losses \> 20% or false positives \> 33%, or false negatives \> 33%;
  • Subjects with history of dementia or multiple sclerosis

Outcomes

Primary Outcomes

Qualitative B-Scan Assessment

Time Frame: 1 day (start: April 29, 2019 - completed: April 30, 2019)

Scores will be based on a 4 point grading scale (0 to 3), with 0 corresponding to failure, 1 is poor, 2 is fair, and 3 is good. The four point scale is defined as follows: 0 indicates the scan is a failure, and contains no clinically useful information. No relevant structures are visible in the scan. 1. indicates the condition of the structure or feature being assessed is poor, and it contains very limited clinical utility. 2. indicates the condition of the structure or feature being assessed is fair or average. It contains some useful clinical information and therefore provides adequate clinical utility. 3. indicates the condition of the structure or feature being assessed is good. It contains useful clinical information. The clinical utility is high or good.

Secondary Outcomes

  • Number of Participants With Adverse Events(1 day)

Study Sites (1)

Loading locations...

Similar Trials